American Society of
Gene and Cell Therapy Annual Meeting Speaker: Olivia Kelly, Ph.D., Senior Director, Cell Biology Presentation: Developing a Cell Therapy Combination Product for Diabetes Date / Time: May 16, 8:30 AM EDT Location: Hilton Chicago, Chicago
Not exact matches
Event: 5th
Annual Cell &
Gene Therapy Investor Day Speaker: Dr. Paul Laikind, President
and Chief Executive Officer Panel:
Cell Therapy Beyond Oncology: Where Does the Greatest Potential Lie?
Data from this trial was previously presented at World Advanced
Therapies and Regenerative Medicine (May 17 - 19,2017; London, UK)
and the 20th
Annual Meeting American Society of
Gene and Cell Therapy (ASGCT, May 10 - 13, 2017; DC, USA).
The 2017
Annual Data Report details industry - specific statistics
and trends from more than 850 leading
cell therapy,
gene therapy, tissue engineering,
and other regenerative medicine companies worldwide.
SAN DIEGO, April 12, 2018 — ViaCyte, Inc., a privately - held regenerative medicine company, today announced President
and CEO, Paul Laikind, Ph.D., will present at Alliance for Regenerative Medicine's 6th
Annual Cell &
Gene Therapy Investor Day in New York.
Drs. Jean Bennett, Luk Vandenberghe, Luca Biasco,
and Francesca Pasinelli will be recognized for their tremendous contributions to
gene and cell therapy at ASGCT's 21st
Annual Meeting.
ASGCT's
annual meeting is the essential scientific conference for professionals in
gene and cell therapy.